ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel
Go back to ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 75.39 +1.80 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.59 | 52 Week High | $70.92 | |||
| Open | $73.68 | 52 Week Low | $26.80 | |||
| Day High | $75.67 | P/E | N/A | |||
| Day Low | $73.54 | EPS | $-0.96 | |||
| Volume | 563,398 | |||||
